Clinical Trial Update: Enhancing the Natriuretic Peptide System in HFpEF [Phase 1, Phase 2]

View source ↗

Summary

This is a Phase 1/Phase 2 clinical trial updating on strategies to enhance the natriuretic peptide system in heart failure with preserved ejection fraction (HFp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Heart Failure with Preserved Ejection Fraction

Snippet

Sponsor: Horng Chen | Conditions: Heart Failure With Preserved Ejection Fraction, Chronic Kidney Diseases | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION